Skip to main content
Premium Trial:

Request an Annual Quote

Bruker AXS Raises $22.5M for X-Ray Systems Development

NEW YORK, Jan 17 – X-ray systems provider Bruker AXS said Wednesday it had raised $22.5 million in a private round of financing.

Bruker AXS said it would allocate a portion of the money towards developing and selling its X-ray systems to structural proteomics companies as an alternative to current crystallography technologies.

" We are presently rolling out proprietary X-ray systems which leapfrog conventional biological crystallography systems in terms of speed and sensitivity,” Martin Haase, president and CEO of Bruker AXS, said in a statement.

“We intend to leverage these technological breakthroughs and first-class customer support with the goal to become the preferred supplier of X-ray solutions for biological crystallography,” he added.

Thomas Weisel Capital Partners led the investment round. Burrill & Company and Other Essex Investment Management also invested in the round.

Bruker AXS of Madison, Wisconsin develops life science and advanced materials research tools based on X-ray technology. The companies revenues exceeded $65 million in 2000.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.